Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.33 B CNY
10.09 B CNY
386.68 M
About CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD.
Sector
Headquarters
Beijing
Founded
1997
Website
ISIN
CNE000000Q94
FIGI
BBG000BJD4G5
China Resources Double-Crane Pharmaceutical Co., Ltd. engages in the processing, manufacture, and sale of pharmaceutical, chemical, and biomedical raw materials. It operates through the following business segments: Infusion and Non-infusion. Its products include compound reserpine flattamine tablets, amlodipine besylate tablets, gliquidone tablets, citicoline sodium tablets, magnesium valproate sustained-release tablets, and soft bags. The company was founded on May 16, 1997 and is headquartered in Beijing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600062 is 20.80 CNY — it has decreased by −5.80% in the past 24 hours. Watch CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stocks are traded under the ticker 600062.
600062 stock has fallen by −4.06% compared to the previous week, the month change is a −14.05% fall, over the last year CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. has showed a 14.47% increase.
We've gathered analysts' opinions on CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. future price: according to them, 600062 price has a max estimate of 29.76 CNY and a min estimate of 25.00 CNY. Watch 600062 chart and read a more detailed CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stock forecast: see what analysts think of CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. and suggest that you do with its stocks.
600062 reached its all-time high on May 12, 2022 with the price of 37.44 CNY, and its all-time low was 1.98 CNY and was reached on Jul 8, 2005. View more price dynamics on 600062 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600062 stock is 6.55% volatile and has beta coefficient of 0.96. Track CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stock price on the chart and check out the list of the most volatile stocks — is CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. there?
Today CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. has the market capitalization of 21.35 B, it has increased by 1.99% over the last week.
Yes, you can track CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. financials in yearly and quarterly reports right on TradingView.
CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
600062 net income for the last quarter is 350.53 M CNY, while the quarter before that showed 630.43 M CNY of net income which accounts for −44.40% change. Track more CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. financial stats to get the full picture.
CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. dividend yield was 1.38% in 2023, and payout ratio reached 19.77%. The year before the numbers were 3.23% and 50.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 24, 2024, the company has 12.27 K employees. See our rating of the largest employees — is CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. on this list?
Like other stocks, 600062 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. stock shows the buy signal. See more of CHINA RESOURCES DOUBLE－CRANE PHARMACEUTICAL CO.,LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.